Non-Profit Gives $800,000 for Melanoma Research in 2009
-Melanoma Research Foundation awards grants to five melanoma researchers-
"People with melanoma desperately need new and improved treatment options. Recognizing that scientific advancements begin in the lab, it is imperative that we support researchers to ensure their work continues," said
Approximately seven years ago, the cancer research community began unlocking the underlying genetic malfunctions that occur in cells causing melanoma. Today, researchers are beginning to correlate those discoveries to therapies that may have a meaningful impact on the survival of patients. Although the melanoma research community is poised to make unprecedented strides in the understanding, prevention and treatment of melanoma, these research efforts have been hindered by the fact that melanoma research is woefully underfunded.
The MRF's Career Development Grant provides funding of up to
"The quality of the research proposals we received this year was unparalleled and created a pool of highly competitive applications," said Meenhard Herlyn, D.V.M., D.Sc., co-chair of the MRF's Scientific Advisory Committee and leader of the Oncogenesis Program at the Wistar Institute in
"Generous donations made to the MRF are the key to funding these potentially life-saving research programs, and the high quality of grant applications this year is testament to the desperate need for greater research funding," said
The most deadly type of skin cancer, melanoma can strike people of all ages, all races and both sexes. In 2008, more than 62,000 Americans were expected to be diagnosed with the disease, resulting in an estimated 8,400 deaths.
In its early stages, melanoma can be successfully removed and monitored by regular skin screenings. However, the disease is deadly in its most advanced stages, as few treatment options exist. The median life expectancy for patients with advanced melanoma is less than one year and existing therapies have not improved survival in more than a decade.
To learn more about donating to MRF and its research programs, please visit www.melanoma.org.
NOTE TO EDITOR: GRANT RECIPIENTS' DETAILS AVAILABLE UPON REQUEST
Melanoma, the most serious type of skin cancer, is one of the fastest growing cancers in the U.S., and can strike people of all ages, all races and both sexes. In fact, with a one in 50 lifetime risk of developing melanoma, more than 62,000 Americans were expected to be diagnosed with the disease in 2008, resulting in an estimated 8,400 deaths. Melanoma is the most common form of cancer for young adults 25 to 29 years old and the second most common cancer in adolescents and young adults 15 to 29 years old.
About Melanoma Research Foundation
The Melanoma Research Foundation (MRF) is the largest independent, national organization devoted to melanoma in
SOURCE Melanoma Research Foundation